Compare Enveric Biosciences Inc (ENVB) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Omnicom Group Inc. — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Omnicom Group Inc. trades at $83.03 (market cap $23.07B). The key difference: Omnicom Group Inc. is far larger — about 4336.5× Enveric Biosciences Inc's market cap, and Omnicom Group Inc. pays a 3.95% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OMC | |
|---|---|---|
Market Cap | $5.32M | $23.07B |
Sector | Health | Media |
52-Week High | $17.40 | $85.80 |
52-Week Low | $1.28 | $67.27 |
Enterprise Value | $408.82K | $30.29B |
Dividend Yield | — | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Omnicom Group (OMC) trades at $80.75, down 2.18% today, with a bullish technical signal from moving averages and a consensus analyst price target of $105.75. Recent earnings show mixed results, with Q1 2026 beating expectations but Q4 2025 missing. The company reported a net loss of $54.5M in 2025 despite revenue growth to $17.27B, though cash flow from operations improved to $2.94B. Key developments include major client wins like IBM and partnerships with streaming platforms, highlighting strategic expansion in digital advertising.
Outlook: OMC offers value with a low P/E of 12.16 and dividend yield support, but risks include intense competition and margin pressure. Upside potential exists if earnings rebound and AI initiatives drive efficiency, yet investors should monitor debt levels and organic growth sustainability amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
